IP Library Granted Patent US 11,191,971
Granted Patent B2
US 11,191,971 · App. 16/812,306 · Granted Dec 7, 2021

Wearable cardioverter defibrillator (WCD) system with active ECG cable shielding

Inventors: Zhong Qun Lu (Everett, WA); Douglas K. Medema (Everett, WA); Kenneth F. Cowan (Kirkland, WA)
Assignee: West Affum Holdings Corp.
A61N1/3904A61N1/046A61N1/0484A61N1/3704A61N1/3968
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,191,971
App. No.
16/812,306
Granted
Dec 7, 2021
Kind
B2
Abstract

Embodiments of a wearable cardioverter defibrillator (WCD) system are configured to monitor a patient's ECG for shockable arrhythmias and deliver a shock to the patient in response to such a detection. To monitor the patient's ECG with reduced signal noise to improve the system's performance, the system includes a cable assembly having: a signal line; an inner shield and an outer shield; an ECG electrode electrically connected to the signal line of the cable assembly; and an amplifier having first and second input nodes respectively connected to the signal line and the outer shield of the cable assembly. The amplifier's output node is electrically connected to the inner shield of the cable assembly to reduce the reactive load seen by the patient's heart in driving the ECG sensing circuitry, which reduces the noise on the ECG signal outputted by the amplifier.

Claims (76)

1. A wearable cardioverter defibrillator (WCD) system for a patient capable of being ambulatory, the WCD system comprising:

an energy storage module configured to store an electrical charge;

a first cable assembly comprising a signal line, an inner shield and an outer shield;

a first ECG electrode electrically connected to the signal line of the first cable assembly;

an amplifier having:

a first input node electrically connected to the signal line of the first cable assembly,

a second input node electrically connected to the outer shield of the first cable assembly, and

an output node electrically connected to the inner shield of the first cable assembly;

at least one therapy electrode;

a support structure configured to be worn by the patient and structured to position the ECG and therapy electrodes to contact a body of the patient while the support structure is worn by the patient; and

one or more processors configured to:

monitor the patient's heart rhythm, wherein monitoring the patient's heart rhythm comprises:

receiving at least one ECG signal via the first cable assembly and the first ECG electrode, and

determining whether the at least one ECG signal meets a shock criterion; and

responsive at least in part to a determination that the shock criterion is met, cause at least some of the stored electrical charge to be discharged from the energy storage device through the at least one therapy electrodes to deliver therapy to the patient.

2. The WCD system of claim 1 , in which the outer shield of the first cable assembly is electrically connected to a ground terminal.

3. The WCD system of claim 1 , in which the first cable assembly comprises a triaxial cable.

4. The WCD system of claim 1 further comprising a hub coupled to support structure, wherein the amplifier is disposed in the hub.

5. The WCD system of claim 1 further comprising a housing, wherein the energy storage device and the one or more processors are disposed in the housing.

6. The WCD system of claim 5 , further comprising a hub, wherein:

the amplifier is disposed in the hub; and

the ECG signal received by the one or more processors is generated from an output signal of the amplifier.

7. The WCD system of claim 6 , wherein the hub further comprises a module including an analog-to-digital converter having:

an input node coupled to the output node of the amplifier; and

an output node coupled to the one or more processors.

8. The WCD system of claim 1 , further comprising:

a second cable assembly comprising a signal line, an inner shield and an outer shield;

a second ECG electrodes electrically coupled to the signal line of the second cable assembly;

a third cable assembly comprising a signal line, an inner shield and an outer shield;

a third ECG electrode electrically coupled to the signal line of the third cable assembly;

a fourth cable assembly comprising a signal line, an inner shield and an outer shield; and

a fourth ECG electrode electrically coupled to the signal line of the fourth cable assembly.

9. The WCD system of claim 8 , in which the outer shield of the first, second, third and fourth cable assemblies are electrically connected to a ground terminal.

10. The WCD system of claim 8 , in which the outer shield of the first, second, third and fourth cable assemblies are electrically connected to a Wilson Central Terminal.

11. A wearable ECG monitoring system for a patient capable of being ambulatory, the system comprising:

a first cable assembly comprising a signal line, an inner shield and an outer shield;

a first ECG electrode electrically connected to the signal line of the first cable assembly;

an amplifier having:

a first input node electrically connected to the signal line of the first cable assembly,

a second input node electrically connected to the outer shield of the first cable assembly, and

an output node electrically connected to the inner shield of the first cable assembly;

a support structure configured to be worn by the patient and structured to position the ECG to contact a body of the patient while the support structure is worn by the patient; and

one or more processors configured to monitor the patient's heart rhythm, wherein monitoring the patient's heart rhythm comprises receiving at least one ECG signal via the first cable assembly and the first ECG electrode.

12. The system of claim 11 , in which the outer shield of the first cable assembly is electrically connected to a ground terminal.

13. The system of claim 11 , in which the first cable assembly comprises a triaxial cable.

14. The system of claim 11 further comprising a hub coupled to support structure, wherein the amplifier is disposed in the hub.

15. The system of claim 11 further comprising a housing, wherein the energy storage device and the one or more processors are disposed in the housing.

16. The system of claim 15 , further comprising a hub, wherein:

the amplifier is disposed in the hub; and

the ECG signal received by the one or more processors is generated from an output signal of the amplifier.

17. The system of claim 16 , wherein the hub further comprises a module including an analog-to-digital converter having:

an input node coupled to the output node of the amplifier; and

an output node coupled to the one or more processors.

18. The system of claim 11 , further comprising:

a second cable assembly comprising a signal line, an inner shield and an outer shield;

a second ECG electrodes electrically coupled to the signal line of the second cable assembly;

a third cable assembly comprising a signal line, an inner shield and an outer shield;

a third ECG electrode electrically coupled to the signal line of the third cable assembly;

a fourth cable assembly comprising a signal line, an inner shield and an outer shield; and

a fourth ECG electrode electrically coupled to the signal line of the fourth cable assembly.

19. The system of claim 18 , in which the outer shield of the first, second, third and fourth cable assemblies are electrically connected to a Wilson Central Terminal.

20. The system of claim 18 , in which the outer shield of the first, second, third and fourth cable assemblies are electrically connected to a ground terminal.

21. The system of claim 20 further comprising an isolated ground terminal, wherein the ground terminal is the isolated ground terminal.

22. The WCD system of claim 9 further comprising an isolated ground terminal, wherein the ground terminal is the isolated ground terminal.

23. A method for use in a wearable cardioverter defibrillator (WCD) system capable of being worn by an ambulatory patient, the method comprising:

storing electrical charge in an energy storage module of the WCD system;

positioning, by a support structure of the WCD system, a first ECG electrode to contact the skin of the patient while the WCD system is being worn by the patient;

coupling the first ECG electrode to a processor of the WCD system using a first cable assembly having at least a signal line, an inner shield and an outer shield, wherein:

a first end of the signal line is electrically connected to the first ECG electrode,

a second end of the signal line is electrically connected to a first input node of an amplifier,

the outer shield is electrically connected to a second input node of the amplifier and to a ground terminal, and

the inner shield is electrically connected to an output node of the amplifier via a resistor;

monitoring the patient's heart rhythm, wherein monitoring the patient's heart rhythm comprises:

receiving at least one ECG signal via the first cable assembly, the first ECG electrode, and the output node of the amplifier, and

determining whether the at least one ECG signal meets a shock criterion; and

responsive at least in part to a determination that the shock criterion is met, cause at least some of the stored electrical charge to be discharged from the energy storage device through at least one therapy electrode to deliver therapy to the patient.

Assignments (4)
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DAC
Reel/Frame 060389/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2020
From: KESTRA MEDICAL TECHNOLOGIES, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 053807/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2020
From: LU, ZHONG QUN; MEDEMA, DOUGLAS K; COWAN, KENNETH F
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 053343/0861 →
Continuity (2)
Provisional Application 62815272 · Mar 7, 2019
Related Publication 20200282224A1 · Sep 10, 2020
Cited By (1)
US 12,300,368